Richa Tyagi

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 3

Top Topics

Molecular Dynamics Simulations

Top Venues

Journal of medicinal chemistry

ACS pharmacology & translational science

This page only lists publications with an associated author ORCID identifier.

Publications

Geoffrey B Varty, Clinton E Canal, Tina A Mueller, Joshua A Hartsel, Richa Tyagi, Ken Avery, Michael E Morgan, Amy C Reichelt, Pradip Pathare, Erik Stang, Michael G Palfreyman, Alex Nivorozhkin
Synthesis and Structure-Activity Relationships of 2,5-Dimethoxy-4-Substituted Phenethylamines and the Discovery of CYB210010: A Potent, Orally Bioavailable and Long-Acting Serotonin 5-HT 2 Receptor Agonist. Journal of medicinal chemistry (2024)
Geoffrey B Varty, Clinton E Canal, Tina A Mueller, Joshua A Hartsel, Richa Tyagi, Ken Avery, Michael E Morgan, Amy C Reichelt, Pradip Pathare, Erik Stang, Michael G Palfreyman, Alex Nivorozhkin
Synthesis and Structure-Activity Relationships of 2,5-Dimethoxy-4-Substituted Phenethylamines and the Discovery of CYB210010: A Potent, Orally Bioavailable and Long-Acting Serotonin 5-HT 2 Receptor Agonist. Journal of medicinal chemistry 67 (8) (2024)
Richa Tyagi, Tanishka S Saraf, Clinton E Canal
The Psychedelic N , N -Dipropyltryptamine Prevents Seizures in a Mouse Model of Fragile X Syndrome via a Mechanism that Appears Independent of Serotonin and Sigma1 Receptors. ACS pharmacology & translational science 6 (10) (2023)